Neogenomics Inc. Daily Stock Analysis

Daily Stock Analysis, NEO, Neogenomics Inc, priceseries

Neogenomics Inc. Daily Stock Analysis
Stock Information
Open
19.56
Close
18.02
High
19.93
Low
17.93
Previous Close
19.52
Daily Price Gain
-1.50
YTD High
35.34
YTD High Date
Jan 4, 2022
YTD Low
17.52
YTD Low Date
Feb 24, 2022
YTD Price Change
-17.26
YTD Gain
-48.92%
52 Week High
54.74
52 Week High Date
Oct 1, 2021
52 Week Low
17.52
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-23.54
52 Week Gain
-56.64%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 31. 2017
7.56
Jul 10. 2017
8.62
27 Trading Days
14.03%
Link
LONG
Apr 11. 2018
8.32
Jun 28. 2018
13.30
55 Trading Days
59.83%
Link
LONG
Oct 23. 2018
14.10
Nov 9. 2018
17.01
13 Trading Days
20.62%
Link
LONG
Jan 4. 2019
12.53
Feb 7. 2019
16.43
23 Trading Days
31.14%
Link
LONG
Mar 28. 2019
19.57
Apr 16. 2019
20.96
13 Trading Days
7.08%
Link
LONG
Oct 28. 2019
20.86
Nov 7. 2019
22.03
8 Trading Days
5.62%
Link
LONG
Jan 9. 2020
29.65
Jan 27. 2020
31.62
11 Trading Days
6.64%
Link
LONG
Jun 29. 2020
29.16
Jul 24. 2020
35.57
18 Trading Days
21.98%
Link
LONG
Oct 5. 2020
37.23
Oct 23. 2020
41.05
14 Trading Days
10.26%
Link
LONG
Nov 20. 2020
44.77
Dec 29. 2020
53.24
25 Trading Days
18.92%
Link
LONG
Jun 4. 2021
40.90
Jun 30. 2021
45.30
18 Trading Days
10.75%
Link
LONG
Aug 20. 2021
43.89
Sep 14. 2021
49.99
16 Trading Days
13.90%
Link
Company Information
Stock Symbol
NEO
Exchange
NasdaqCM
Company URL
http://www.neogenomics.com
Company Phone
9419231949
CEO
Douglas M. Van Oort
Headquarters
Florida
Business Address
12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS, FL 33913
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001077183
About

NeoGenomics, Inc. operates a network of cancer focused testing laboratories to provide genetic and molecular testing services. The company offers various testing services, including Cytogenetics, Fluorescence In-Situ Hybridization, Flow Cytometry, Immunohistochemistry, Hematopathology, Hereditary Cancer, Molecular Oncology and Pathology. The company operates through one segment: Laboratory Testing Segment. The Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Description

NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading